Ensysce Biosciences, Inc.
ENSCNASDAQHealthcare● Active
$0.24
$-0.01(-3.70%)
Market Cap$2270283
P/E Ratio—
52W High$2.75
52W Low$0.23
Ensysce Biosciences, Inc.（ENSC）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ENSC · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.07M | $5.21M | $2.23M | $2.52M | $3.53M |
| Cost of Revenue | $0.00M | $7.22M | $7.59M | $19.84M | $0.00M |
| Gross Profit | $0.00M | ($2.01M) | ($5.36M) | ($17.31M) | $3.53M |
| Gross Margin %(computed) | 0.00% | -38.57% | -240.12% | -686.08% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $10.38M | $7.22M | $7.59M | $19.84M | $4.69M |
| G&A Expenses | $4.93M | $4.72M | $5.36M | $6.91M | $0.00M |
| Total Operating Expenses | $10.24M | $4.72M | $5.36M | $6.91M | $23.40M |
| Operating Income | ($10.24M) | ($6.73M) | ($10.72M) | ($24.22M) | ($19.87M) |
| Operating Margin %(computed) | -202.12% | -129.17% | -480.41% | -959.91% | -562.71% |
| Interest Income | $0.00M | $0.00M | $0.00M | $1.25M | $3.21M |
| Interest Expense | $0.02M | $1.29M | $0.35M | $0.11M | $1.29M |
| Income Before Tax | ($10.18M) | ($7.99M) | ($10.63M) | ($24.21M) | ($29.15M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($10.18M) | ($7.99M) | ($10.61M) | ($24.17M) | ($29.08M) |
| Net Margin %(computed) | -200.84% | -153.30% | -475.71% | -957.93% | -823.62% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.98 | $-4.57 | $-4.69 | $-139.44 | $-355.68 |
| Wtd Avg Shares | 2.56M | 1.75M | 2.26M | 0.18M | 0.08M |
| EBITDA | ($10.15M) | ($6.73M) | ($10.72M) | ($24.22M) | ($25.93M) |
| EBITDA Margin %(computed) | -200.35% | -129.17% | -480.41% | -959.90% | -734.32% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Ensysce Biosciences, Inc.
关于Ensysce Biosciences, Inc.（ENSC）损益表
Ensysce Biosciences, Inc.（ENSC）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ENSC实现营收$0.01B，毛利润$0.00B（毛利率0.00%），净利润($0.01B)（净利率-200.84%）。
常见问题
ENSC · 4 问Ensysce Biosciences, Inc.（ENSC）2025财年营收为$0.01B，同比down2.8%。
ENSC revenueENSC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08